Malaria vaccine a ‘breakthrough for science’, WHO chief says
Aljazeera says The World Health Organization (WHO) said on Wednesday the only approved vaccine against malaria should be widely given to African children, marking a major advance against a disease that kills hundreds of thousands of people annually.
The WHO recommendation is for RTS,S, sold as “Mosquirix”, a vaccine developed by British drugmaker GlaxoSmithKline.
Since 2019, 2.3 million doses of Mosquirix have been administered to infants in Ghana, Kenya and Malawi in a large-scale pilot programme coordinated by the WHO. The majority of those whom the disease kills are aged under five.
FOLLOW US ON SOCIAL MEDIA AND SHARE WTX NEWS WITH YOUR FRIENDS AND FAMILY:
Facebook – Please like our page
Twitter – Twitter updates available in English and Arabic. Please follow us and we would love to hear from you
Instagram – Follow our pages in English and Arabic